InMed Pharmaceuticals registers 3.9M shares for resale

• InMed Pharmaceuticals (NASDAQ:INM) has filed a prospectus for the resale of up to 3.90M common shares by a selling shareholder and its permitted transferees.
• The offering includes 1.95M shares from pre-funded warrants and 1.95M shares from preferred investment options, both issued under a private placement.
• InMed will not receive proceeds from the resale of shares but may receive up to $4.76M from the exercise of preferred investment options, and $195 from pre-funded warrants if exercised for cash.
• Source: SEC filing

More on InMed Pharmaceuticals

• InMed Pharmaceuticals announces $5M private placement
• Financial information for InMed Pharmaceuticals